Skip to main content
Clinical Trials/NCT04459975
NCT04459975
Unknown
Not Applicable

Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units

Hospices Civils de Lyon1 site in 1 country200 target enrollmentApril 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
on Occurrence of Acurate Kidney Injury During Intensive Care Unit
Sponsor
Hospices Civils de Lyon
Enrollment
200
Locations
1
Primary Endpoint
Primary endpoint is the incidence, the severity and the mortality associated with AKI during COVID-19 severe infection
Last Updated
5 years ago

Overview

Brief Summary

The actual COVID-19 epidemy is an unprecedented healthcare problem. Although acute respiratory distress syndrome is the main organ failure, acute kidney injury (AKI) has appeared to be more frequent and more severe than expected. Some data suggested a potential direct renal tropism of the virus, or undirect injury by "cytokine storm".

The aims of this study are:

  1. To describe incidence, severity and mortality associated with AKI during covid-19 infection in ICU
  2. To identify specific risk factors for AKI
  3. To explore pathophysiologic mechanism of AKI during COVID-19 infection
Registry
clinicaltrials.gov
Start Date
April 1, 2020
End Date
November 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Confirmed COVID-19 infection (by qRT-PCR and/or TDM typical lesion)
  • Needing intensive care

Exclusion Criteria

  • End Stage Renal Disease patients (with pre-existent dialysis)
  • Intensive care support for less than 72h (transfer in conventional unit or death)

Outcomes

Primary Outcomes

Primary endpoint is the incidence, the severity and the mortality associated with AKI during COVID-19 severe infection

Time Frame: 7 months

AKI will be defined according with KDIGO guidelines: increase in creatinine of more than 1,5 fold compared to baseline Severe CVOID-19 infection is defined as 1/ confirm COVID-19 infection (by TDM and/or qRT-PCR) 2/ Requirement of ICU support during more than 72h

Study Sites (1)

Loading locations...

Similar Trials